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NF–IL-6 is a member of the C/EBP family of transcrip-*Department of Microbiology
tion factors, which are related by homology in their basicColumbia University College of Physicians
DNA binding motif and leucine zipper dimerization (bzip)and Surgeons
domain (Vinson et al., 1989). This family includes theNew York, New York 10032
transcriptional activators, C/EBPa, C/EBPd, CRP1, and†Aaron Diamond AIDS Research Center
NF–IL-6 (C/EBPb) and dominant negative proteins LIP,445 First Avenue
immunoglobulin (Ig)/EBP (C/EBPg), and CHOP-10 (AkiraNew York, New York 10016
and Kishimoto, 1992; Cao et al., 1991; Descombes and
Schibler, 1991; Roman et al., 1990; Ron et al., 1991;
Williams et al., 1991). NF–IL-6 is the only member of this
Summary family that appears to be induced during monocyte/
macrophage differentiation and activation (Akira and
Previous work has shown that C/EBP sites and C/EBP Kishimoto, 1992; Henderson et al., 1995; Natsuka et al.,
transcriptional activators are necessary for HIV-1 LTR 1992).
activity in monocytes/macrophages. We have investi- Within an HIV-1-infected host, there appears to be a
gated the role that C/EBP proteins play in induction mixture of infected cells, some that actively produce
and replication of HIV-1. Ectopic expression of the virus and others that harbor proviral DNA, either inte-
dominant negative C/EBP protein LIP inhibited HIV-1 grated or nonintegrated, but do not produce virus. Cells
mRNAand virus production in activated U1 cells, dem- carrying viral genomes, which are transcriptionally si-
onstrating that C/EBP proteins are required for provi- lent, but can be induced to transcribe the provirus, have
rus induction. U1lines overexpressingC/EBP activator been observed in both humans and chimpanzees (Em-
NF–IL-6 produced more viral mRNA and virus particles bretson et al., 1993; McCune, 1995; Saksela et al., 1993;
following cellular activation than control lines, demon- Schnittman et al., 1989). Cytokines that activate T cells
strating that C/EBP proteins are limiting for virus tran- and monocytes/macrophages and drive their further dif-
scription. HIV-1 harboring mutationswithin two C/EBP ferentiation also induce transcription and replication of
sites were crippled in their ability to replicate in U937 latent HIV-1 provirus, thus altering the balance of virus-
promonocytic cells, indicating that these sites are re- producing cells in the infected host (Fauci, 1993).
quired for replication. These data identify C/EBP pro- U1 cells are promonocytes that provide an in vitro
model for postintegration latency of HIV-1 (Folkes et al.,teins as regulators of HIV-1 expression in monocytes/
1987, 1988; Kinter et al., 1990). U1 cells harbor a latentmacrophages.
HIV-1 provirus that is transcribed at low levels until the
cells are treated with reagents such as cytokines, lipo-
Introduction polysaccharide (LPS), or phorbol esters, which activate
the cells and trigger their differentiation (Folkes et al.,
Monocytes/macrophages are important targets for 1988; Kinter et al., 1990; Pomerantz et al., 1990). Lack
HIV-1 infection and may provide a reservoir of HIV-1 for of HIV-1 replication prior to cellular activation in U1 cells
persistent infection and virus dessemination. In addi- appears to result from a deficiency of cellular proteins
tion, monocytic cells are involved in AIDS-related pa- necessary for HIV-1 LTR promoter activity (Chen et al.,
thology of the brain, lungs, skin, and lymph nodes (Fauci, 1994). Thus, U1 cells provide a good system for identi-
1988; Gartner et al., 1986). Inflammatory cytokines pro- fying host cell factors that are necessary for induction
duced by activated macrophages are elevated in AIDS of HIV-1 provirus transcription. NF-kB is involved in the
(Poli et al., 1994a). These cytokines cause differentiation induction of HIV-1 expression in U1 cells (Griffin et al.,
of macrophages and induce expression of latent HIV-1 1989; Pomerantz et al., 1990; Roulston et al., 1992).
provirus. NF-kB, an activator of HIV-1 transcription, has However, there have been reports of viral induction in
previously been shown to be induced in monocytes/ U1 cells by NF-kB-independent mechanisms (Poli et al.,
macrophages upon cytokine-dependent activation and 1994b; Sakaguchi et al., 1991).
HIV-1 infection (Baeuerle and Henkel, 1994; Griffin et In previous studies, we demonstrated that C/EBP pro-
al., 1989; Pomerantz et al., 1990; Roulston et al., 1992; teins and at least one C/EBP binding site are required
Suzan et al., 1991). In addition, recent work has shown for HIV-1 LTR promoter activity in U937 promonocytes
that the C/EBP family protein nuclear factor–inter- (Henderson et al., 1995). Here, we show that the C/EBP
leukin-6 (NF–IL-6) is also induced upon monocyte/mac- dominant negative protein LIP strongly inhibits the in-
rophage activation (Natsuka et al., 1992), and that there duction of provirus following activation of U1 cells, dem-
are C/EBP binding sites within the HIV-1 long terminal onstrating that C/EBP proteins are required for induction
repeat (LTR) (Tesmer et al., 1993) that are necessary for of HIV-1 in U1 cells. Overexpression of NF–IL-6 was not
LTR promoter activity (Henderson et al., 1995). Thus, sufficient to induce provirus; however, after activation
NF–IL-6appears tobe a second inducible transcriptional by LPS/phorbol myristate acetate (PMA), U1 cells ex-
activator, which is important for HIV-1 expression in pressing elevated levels of NF–IL-6 produced signifi-
cantly more HIV-1 than control cells. These data confirmmonocytes/macrophages. Here, we report experiments
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that C/EBP proteinsare important for HIV-1 transcription
and show that C/EBP proteins are limiting for virus ex-
pression even after activation of U1 cells. Finally, we
demonstrate that HIV-1 replication in monocytes/mac-
rophages requires C/EBP binding sites, since viruses
harboring mutationswithin thesesites replicatepoorly in
U937 promonocytic cells. These results identify C/EBP
proteins as critical transcriptional activators that regu-
late HIV-1 replication in monocytic cell lines.
Results
Generation of U1 Sublines Expressing
Ectopic LIP or NF–IL-6
To investigate whether C/EBP proteins are involved in
regulating HIV-1 transcription, U1 cell lines that overex-
press the dominant negative protein LIP or the transcrip-
tional activator NF–IL-6 were generated. Both constitu-
tive and regulated expression systems were used. The
first strategy utilized the tetracycline-regulated pro-
moter system previously described (Gossen and Bujard,
1992). This promoter, which contains tet operator se-
quences and a minimal cytomegalovirus (CMV) pro-
moter, is activated by tetracycline transcriptional activa-
tor (tTA) protein. In the absence of tetracycline, tTA binds
the tetracycline-sensitive promoter and activates tran-
scription. However, in the presence of tetracycline, tTA
cannot bind its DNA recognition sequence and cannot
activate transcription (Gossen and Bujard, 1992). Con-
trol U1 lines were also generated that were stably
transfected with the tTA expression plasmid and a con-
trol plasmid.
Expression of NF–IL-6 or LIP was monitored by immu-
noblots. As shown in Figure 1, U1 lines were generated
that overexpressed NF–IL-6 or LIP in the absence of
tetracycline. The NF–IL-6 levels were 3–9 times greater
than endogenous protein and LIP levels were 2–4 times
higher than endogenous levels. When tetracycline was
added to the culture medium, 5 of 18 of the NF–IL-6
lines decreased their expression of NF–IL-6 (Figure 1A;
data not shown). Figure 1A shows three of these lines
in which protein levels were decreased 2.5- to 7-fold by Figure 1. U1 Stable Cell Lines Overexpress NF–IL-6 or LIP
the addition of 2 mg/ml of tetracycline, indicating that (A) Immunoblot of U1 mock-transfected cells and NF–IL-6-stable
we could modulate NF–IL-6 expression. However, for cell lines, 4, 19, and 24, that were cultured in the absence (lanes 1,
3, 5, and 7) or presence of 2 mg/ml of tetracycline (lanes 2, 4, 6, andreasons we do not understand, none of the 15 LIP cell
8) for 48 hr. Nuclear extracts were prepared from these cells andlines examined demonstrated tetracycline-sensitive
run on a 10% SDS–PAGE gel. NF–IL-6 was detected as described.regulation (data not shown). U1 lines in which LIP was
(B) Immunoblots of several LIP-stable cell lines. Whole cell lysates
constitutivelyoverexpressed from a CMV promoter were were prepared and separated on a 12% SDS–PAGE gel. These data
also generated. LIP levels were increased by at least are representative of 15 LIP-overexpressing cell lines.
3-fold in these cell lines (Figure 1B, lane 7).
All of the NF–IL-6- and LIP-expressing lines grew at
rates similar to the U1 control cells (Figure 2A).To assess 2B, panel 3). LPS/PMA treatment increased the expres-
sion of CD11b and CD54 expression in all three cell linestheir state of differentiation, representative lines were
analyzed for the presence of the cell surface proteins (Figure 2B, panels 2 and 4). However, the different cell
lines did not increase theirexpression of these individualCD11b (Mac 1) and CD54 (ICAM-1) (Figure 2B). Prior
to stimulation only minor differences were observed. markers to the same extent. The LIP line expressed
significantly less CD11b and CD54 following LPS/PMAApproximately 5% of the control and LIP-expressing
cells displayed CD11b, whereas 13.5% of the NF–IL-6- treatment, whereas the NF–IL-6 line expressed signifi-
cantly higher levels of CD54 compared with U1 controlexpressing cells expressed this marker (Figure2B, panel
1). CD54 was displayed at comparable levels on the cells (Figure 2B, panels 2 and 4). These data demon-
strate that while both NF–IL-6- and LIP-expressing linessurface of U1 and LIP-expressing cells but was present
at higher levels in the NF–IL-6-expressing lines (Figure were capable of undergoing differentiation in response
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Figure 3. Induction of HIV-1 Replication Is Inhibited in U1-LIP Cell
Lines
We cultured 1 3 106 cells/ml of mock-transfected U1 cells or various
LIP stable lines in the absence or presence of 10 mg/ml LPS and
10 ng/ml PMA for 48 hr. After 48 hr, supernatants were collected
and RT assays were performed to determine virus production. Data
are presented as RT activity relative to unstimulated cells. There
were no significant differences observed in RT activity in the unstim-
ulated lines. LIP pool refers to a nonclonally selected cell population.
Open bars represent untreated cells and closed bars indicate cells
treated with LPS/PMA. Each bar represents an average of at least
three individual experiments performed in triplicate.
of LIP would be expected to inhibit the production of
virus. This was tested with the LIP stable cell lines.
Reverse transcriptase (RT) assays were performed onFigure 2. NF–IL-6- and LIP-Stable Lines Have Similar Growth Rates
culture medium to measure the relative number of viri-but Differentially Express Surface Antigens
ons produced by these cell lines. Prior to activation,(A) Various cell lines were cultured at 1 3 105 cells/ml and at the
indicated timepoints aliquots were removed and counted. These only very low levels of RT activity could be detected in
data are from a single experiment that is representative of two the culture supernatants from any of the cell lines (Figure
independent experiments. 3). Following LPS/PMA treatment, a 21-fold increase in
(B) FACS analysis of the various cell lines prior to stimulation (panels RT activity was observed in the supernatant of control
1, 3) and following treatment with 10 mg/ml LPS and 10 ng/ml PMA
mock-transfected U1 cells (Figure 3). In contrast, the(panels 2, 4). Cells were stained with CD11b (panels 1 and 2) and
cell lines overexpressing LIP produced dramatically lessCD54 (panels 3 and 4). Mock-transfected U1 cells are represented
by the solid line, the NF–IL-6-stable cell line 4 is represented by virus following activation when compared with U1 cells.
the broken line, and the CMV-LIP stable line is represented by the The RT activities for LIP lines 6, 9, and 13 were reduced
stippled line. The dotted line represents U1 cells stainedwith second by more than 3-fold and the CMV–LIP line, the initial
antibody alone and this represents the profiles observed with all pool of LIP cells, and lines 5, 7, 8, 20, and 21 were
the cell lines when stained for second antibody alone.
decreased between 4- and 17.5-fold (Figure 3), ap-
proaching nonactivated levels in some cases. Although
all the lines overexpressing LIP showed a significantto LPS/PMA, overexpression of these proteins altered
the differentiative state or the potential of the cells, or decrease in virus production, there was not a strict cor-
relation between LIP levels and the magnitude of theboth, as evidenced by expression of surface markers.
decrease in different lines. We do not know whether
the differences between LIP-overexpressing sublinesOverexpression of LIP Inhibits HIV-1 Particle
Release Following Activation of U1 Cells results from different levels of endogenous C/EBP acti-
vators or other genetic differences. However, the resultsLIP is a member of the C/EBP family that lacks a strong
activation domain but retains the bzip region (Des- clearly show that overexpression of the C/EBP dominant
negative protein LIP inhibits HIV-1 virus production,combes and Schibler, 1991). LIP has been shown to
have dominant negative activity in several cell types, which normally occurs following activation of U1 cells
with LPS/PMA.probably owing to its abilities to compete for C/EBP
binding sites and to form nonfunctional heterodimers
with C/EBP activators. Previous experiments have dem- LIP Overexpression Inhibits HIV-1
Provirus Transcriptsonstrated that LIP can inhibit the activity of the HIV-1
LTR in transient transfections, suggesting that C/EBP Since LIP is a dominant negative transcription protein,
it seemed likely that its inhibitory effect on virus produc-proteins are involved in regulating the transcription of
HIV-1 (Henderson et al., 1995). If C/EBP proteins are tion was due to changes in HIV-1 provirus transcription.
To test this, the levels of HIV-1 steady-state mRNA wererequired for the induction of HIV-1, then overexpression
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4B). The steady-state HIV-1 mRNA levels correlated well
with the RT values for virus particles, consistent with
the idea that induction is at the level of transcription,
as shown in previous studies (Chen et al., 1994). The
variation in mRNA levels between the individual LIP-
overexpressing lines probably reflects inherent differ-
ences that may have arisen during selection. These re-
sults demonstrate that LIP inhibits normal levels of HIV-1
RNA and subsequent virus production, which occur
upon activation of U1 cells. We therefore conclude that
C/EBP transcriptional activators are required for tran-
scription of HIV-1 provirus upon activation of U1 cells.
Overexpression of NF–IL-6 Increases HIV-1
Transcripts and Virus Release Following
Activation of U1 Cells
NF–IL-6 is the only C/EBP family member induced upon
activation of U937 cells, the parent line from which U1
cells were derived (Akira and Kishimoto, 1992; Hender-
son et al., 1995; Natsuka et al., 1992). Therefore, we
hypothesized that NF–IL-6 was likely to play an impor-
tant role in provirus induction. The NF–IL-6-overex-
pressing U1 cell lines were used to test this hypothesis.
To determine whether the presence of NF–IL-6 could
alter virus expression in U1 cells, RT activity was mea-
sured in culture supernatants before and after cellular
activation. Prior to activation, RT activity was low for all
the cell lines tested. There was no significant difference
in the RT values for mock-transfected U1 cells com-
pared with the lines overexpressing NF–IL-6 (Figure 5).
This demonstrates that overexpression of NF–IL-6 is not
sufficient toactivate HIV-1 provirus in U1 cells. However,
following LPS/PMA stimulation the NF–IL-6-overex-
pressing lines consistently produced more virus than
controls. HIV-1 production in control U1 cells increased
by approximately 13-fold, whereas the cell lines thatFigure 4. Induction of HIV-1 mRNA Is Inhibited in U1-LIP Lines
ectopically expressed NF–IL-6, 4, 19, and 24 induced
(A) RNase protection assay of total RNA prepared from different
virus by 56-fold, 40-fold, and 34-fold, respectively (Fig-U1-derived cell lines. We cultured 1 3 106 cells/ml in the absence
ure 5).or presence of 10 mg/ml LPS and 10 ng/ml PMA for 24 hr prior to
preparing RNA. Arrows indicate the protected fragments for HIV-1 If the increased induction of HIV-1 isa result of overex-
and b-actin. Upon longer exposures HIV-1 RNA could be detected pressing NF–IL-6, then decreasing the levels of this fac-
in unstimulated cells (data not shown). tor by culturing the cells in the presence of tetracycline
(B) Summary of RNase protection assay for several U1-LIP lines.
should diminish their ability to produce virus. CulturingData were normalized for b-actin signal. Open bars represents un-
the control U1 cells in 2 mg/ml of tetracycline did nottreated cells and closed bars are cells treated with LPS/PMA. These
significantly alter the levels of virus released before ordata summarizes three individual experiments.
after LPS/PMA treatment, indicating that tetracycline
alone does not inhibit HIV-1 replication (Figure 5). How-
ever, the RT activity of the NF–IL-6-overexpressing cellquantified using a riboprobe assay in mock-transfected
controls and LIP-overexpressing U1 lines. A single- lines was decreased 2- to 3-fold in the presence of
tetracycline (Figure 5).This decrease inRT activity corre-stranded antisense RNA probe that could detect all the
spliced products of HIV-1 mRNA was synthesized from lated with a decrease in the levels of NF–IL-6 for these
cell lines (see Figure 1; Figure 5). This result indicatesthe HIV-1 LTR. This probe would be expected to detect
two HIV-1-specific fragments, a fragment of 110 bp and that the observed changes in RT activity following LPS/
PMA activation of the NF–IL-6 stable cell lines are aa larger fragment of 480 bp. As a control, a b-actin
probe, which detects a fragment of 80 bp, was also result of ectopic NF–IL-6 expression rather than other
changes that the cells might have undergone duringused. As shown in Figure 4, prior to cellular activation
only low levels of HIV-1 mRNA were detected. However, transfection and selection. Furthermore, these data
demonstrate that although NF–IL-6 alone cannot induceafter LPS/PMA treatment, HIV-1 mRNA in control U1
cells increased significantly (Figure 4). All of the LIP- HIV-1 provirus in U1 cells, it acts as a positive factor
following activation by LPS/PMA, resulting in increasedoverexpressing lines had 2- to 20-fold less HIV-1 mRNA
than the control line following cellular activation (Figure virus production.
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Figure 5. Overexpression of NF–IL-6 Results
in Increase HIV-1 Replication Following Acti-
vation
We cultured 1 3 106 cells/ml of mock-
transfected U1 cells or NF–IL-6-stable cell
lines in the absence (open bars) or presence
of 2 mg/ml tetracycline (stippled bars), 10 mg/
ml LPS plus 10 ng/ml PMA (closed bars), or
tetracycline plus LPS/PMA (hatched bars) for
48 hr. Data are presented as RT activity rela-
tive to unstimulated cells. There were no sig-
nificant differences observed in RT activity in
the unstimulated lines. Each bar represents
an average of at least three individual experi-
ments performed in triplicate.
The riboprobe assay was also used to quantitate to 4.5-fold greater than that observed in the U1 line
(Figure 6B). In addition, after treatment with tetracycline,steady-state levels of HIV-1 transcripts in the NF–IL-6-
overexpressing lines. LPS/PMA activation of control U1 less mRNA was present in the NF–IL-6 lines (Figure 6B).
Northern blot analysis demonstrated there was nocells resulted in a 25-fold increase in the levels of HIV-1
mRNA (Figure 6A). HIV-1 mRNA from the NF–IL-6-over- change in the relative amounts of the different spliced
mRNAs in controls versus NF–IL-6-overexpressing linesexpressing lines following LPS/PMA activation was 2.5-
Figure 6. Overexpression of NF–IL-6 Increase HIV-1 mRNA Following Activation
(A) RNase protection assay of total RNA prepared from cells cultured in the absence or presence of 10 mg/ml LPS plus 10 ng/ml PMA or 2
mg/ml tetracycline, or both for 24 hr. Upon longer exposures, HIV-1 RNA could be detected in unstimulated cells (data not shown).
(B) Summary of RNase protection assays. Untreated cells are represented by open bars, and cells cultured with tetracycline, LPS/PMA, or
tetracycline plus LPS/PMA are indicated by stippled bars, closed bars, or grey bars respectively. Data were normalized for b-actin signal.
These data represent three individual experiments.
(C) Northern blot of total RNA from U1 cells and NF–IL-6, line 24, following various treatments.
Immunity
96
Figure 7. C/EBP Sites Are Required for HIV-1 Replication
(A) Strategy for introducing C/EBP mutations into the HIV-1 provirus. mC2,C3 mutations (represented by the X) were cloned into the 39 LTR
of HXB2. Wild-type and mutant virus stocks, generated by transfecting 293T cells, were used to infect U937 cells. Following reverse transcription
and DNA integration, the mutations will be copied into the 59 LTR. Large arrows represent transcriptional start sites. Arrowheads represent
primers used for PCR to detect proviral DNA (see Experimental Procedures). Bars represent predicted PCR products using these primers.
(B) mC2,C3 HXB2 virus infects U937 cells. Genomic DNA was prepared from uninfected cells (lane 1 and 4), or cells 24 hr postinfection with
mC2,C3 HXB2 (lanes 2 and 5), or HXB2 (lanes 3 and 6). A specific LTR PCR product of 318 bp, which is indicated by the arrow, is expected
and was detected by Southern blot hybridization using the mC3-specific probe. This probe will detect all specific PCR products when washed
with 0.23 SSC, 0.1% SDS at 258C (lanes 1–3) but will specifically bind the mC3 sequence after more stringent washes at 508C (lanes 4–6).
(C) RT assay of cells infected with wild-type HXB2 and mC2,C3 HXB2. U937 cells were cultured at 1 3 106 cells/ml and infected with virus
stocks. At various times, supernatants were collected and RT assays were performed. RT activity was determined using a phosphorimager.
These data are from a single experiment that is representative of four independent experiments. Each data point represents three individual
infections. The error bars for the mC2,C3 HXB2 virus are not apparent due to the scale of the y-axis.
(Figure 6C). These findings corroborate the RT data and inhibit the activity of LTR-dependent reporters in tran-
sient transfections (Henderson et al., 1995). The muta-support the conclusion that ectopic expression of
NF–IL-6 increases HIV-1 transcription following cellular tions were engineered into the 39 LTR of HXB2 and
infectious particles were generated by transient trans-activation, resulting in an increase in the release of virus.
fection of 293T cells (Figure 7A). Since viral transcripts
initiate from the wild-type 59 LTR in both wild-type andC/EBP Sites Are Required for HIV-1
Replication in U937 Cells mutant constructs, differences in virus production were
not anticipated. This was confirmed by measuring RTPrevious studies using transient transfection of HIV-1
LTR-dependent reporters showed that one of the two activities from 293T cell supernatants containing wild-
type HXB2 and mC2,C3 HXB2 viruses (data not shown).39 C/EBP sites is required for full HIV-1 LTR promoter
activity (Henderson et al., 1995). Thus, we imagined that Upon infection of U937 cells and reverse transcription,
the C/EBP site mutations will be copied into the 59 LTRC/EBP proteins acted directly on their LTR binding sites
to affect provirus induction in U1 cells. However, C/EBP of the provirus (Figure 7A). To confirm that mutant vi-
ruses did successfully infect U937 cells, polymeraseproteins also activate cytokine gene transcription (Akira
and Kishimoto, 1992) and these cytokines could possi- chain reaction (PCR) analysis was performed on geno-
mic DNA 24 hr postinfection (Figure 7B). A PCR productbly affect provirus induction. Therefore, we designed
experiments to test the hypothesis that C/EBP proteins containing the mutated sites could not be generated
by contaminating DNA from the transfections since theact directly on their proviral LTR binding sites. Viruses
were generated that harbored site-directed mutations mC2,C3 construct lacks sequences that would bind the
downstream primer (Figure 7A). An oligonucleotidein the two 39 C/EBP sites (C2 [2178 to 2159] and C3
[2120 to 2109]); these were the same mutations that probe that spanned the C3 mutation was used to detect
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the specific PCR products. This probe hybridized to or steady-state HIV-1 mRNA levels in U1 cells. However,
cell lines overexpressingNF–IL-6 did contain more HIV-1products amplified from both wild-type and mC2,C3 se-
quences under low stringency conditions (Figure 7B, mRNA following activation. Thus, although NF–IL-6 is
required for HIV-1 transcription, additional changes arelanes 1–3) but was specific for the C3 mutation when
the stringency was increased (Figure 7B, lanes 4–6). also required for HIV-1 induction in U1 cells. What might
those change(s) be? A number of possibilities exist thatThus, the mC2,C3 HXB2 virus is packaged normally and
is capable of infecting U937 cells. are not mutually exclusive.
NF-kB binding sites are known to be required for fullTo determine how the C/EBP site mutations affected
virus replication, U937 cells were infected with wild-type HIV-1 LTR transcriptional activity in T cells and mono-
cytic cells, and NF-kB (p65 and p50) is increased uponHXB2 and mC2,C3 HXB2 viruses and RT activity was
monitored at various times following infection to assess U1 activation (Griffin et al., 1989, 1991; Nabel and Balti-
more, 1987; Pomerantz et al., 1990; Roulston et al.,virus production. As shown in Figure 7C, RT values were
5-fold less in cells infected with the HIV-1 virus harboring 1992). In addition, it has beendemonstrated that NF–IL-6
and NF-kB subunits can physically interact and this in-the C/EBP mutations when compared with wild-type
HXB2 5 days after infection. By 3 weeks, mC2,C3 HXB2 teraction can result in a synergistic increase in their
transcriptional activity (LeClair et al., 1992; Stein et al.,was 17-fold lower than wild-type HXB2 (Figure 7C).
These data demonstrate that at least one of the two 1993). Therefore, it is possible that NF-kB/Rel proteins
synergize with NF–IL-6 on the HIV-1 LTR. U1 lines over-39 C/EBP sites is required for normal levels of virus
replication and demonstrate a direct role for C/EBP pro- expressing p65 or p50 have not been reported, but it
seems likely that they might have properties similar toteins in virus replication.
the NF–IL-6-overexpressing lines if both proteins are
required for HIV-1 induction. In addition, other transcrip-Discussion
tion proteins, either activators, coactivators, or compo-
nents of the basal transcription machinery, that are nec-C/EBP Family Transcriptional Activators
essary for HIV-1 transcription may have increasedAre Required for HIV-1 Replication
activity upon U1 cell activation (Sakaguchi et al., 1991).Previous studies showed that cotransfected NF–IL-6
Another possibility is that activation of U1 cells withcould activate the HIV-1 LTR and that C/EBP proteins
LPS/PMA initiates a cascade that results in phosphory-and binding sites were necessary for HIV-1 LTR activity
lation of NF–IL-6, a step that may be required before itin U937 promonocytes (Henderson et al., 1995; Tesmer
can activate HIV-1 transcription efficiently. Previouset al., 1993). However, these studies utilized LTR re-
work has shown that serine and threonine residues inporter constructs and transient transfections and did
NF–IL-6 are phosphorylated in response to different sig-not address how C/EBP proteins might act during an
nal transduction pathways (Metz and Ziff, 1991; Naka-active HIV-1 infection or on latent HIV-1 provirus. Al-
jima et al., 1993; Trautwein et al., 1993, 1994; Wegnerthough NF–IL-6 is known to be increased after mono-
et al., 1992). Some of these phosphorylated residuescyte/macrophage activation, its role in the induction of
are located in the activation and leucine zipper domainslatent HIV-1 is not established. The experiments pre-
and their phosphorylation increases the ability of NF–sented here show that overexpression of NF–IL-6 can
IL-6 to transactivate but not its ability to bind DNA orincrease HIV-1 transcription following activation and
form homodimers (Trautwein et al., 1993; Wegner et al.,that a dominant negative inhibitor of C/EBP activators,
1992). In addition, phosphorylation may also influenceLIP, significantly inhibits HIV-1 provirus transcription
the intracellular localization of NF–IL-6 (Metz and Ziff,and replication following cellular activation. Further-
1991) or its ability to bind DNA (Metz and Ziff, 1991;more,mutating the C/EBP sites in theHIV-1 LTR resulted
Trautwein et al., 1994). The phosphorylation state ofin a dramatic decrease in virus replication. These results
NF–IL-6 in monocytes/macrophages before and afterdirectly establish an important role for C/EBP activators
activation is not known, but the NF–IL-6-overexpressingin HIV-1 replication and in induction of latent proviruses.
U1 lines provide a useful tool for further study of thisA requirement for C/EBP activators could explain the
question.results of Poli and colleagues (1994b) who noted an NF-
kB-independent mechanism for HIV-1 induction after
treatment of U1 cells with IL-1b or IL-6, since IL-1 and NF–IL-6 Directly Regulates HIV-1 Transcription
IL-6 are known to induce transcription of NF–IL-6 (Nat- and Is a Component of Autocrine Stimulation
suka et al., 1992). It is not known whether there is a Paths in Macrophages
similar requirement for C/EBP proteins for transcription The failure of the LIP-expressing cell lines to fully induce
of HIV-1 in CD41 T cells. latent HIV-1 establishes a requirement for C/EBP activa-
tors in provirus induction; however, it does not distin-
guish between direct, indirect, or combination effectsNF–IL-6 Is Not Sufficient to Induce HIV-1
Provirus in U1 Cells of NF–IL-6 on the HIV-1 LTR. Viruses with mutated
C/EBP sites were used in this study to establish thatIt has previously been shown that failure of the HIV-1
provirus to be transcribed in U1 cells prior to activation C/EBP proteins act directly on the HIV-1 LTR. Viruses
with mutations in the two 39 C/EBP sites infected U937is caused by the cellular environment (Chen et al., 1994).
Presumably one or more necessary transcriptional acti- cells but after multiple rounds of infection and replica-
tion, produced less than 10% of wild-type virus particles.vators is lacking. Overexpression of NF–IL-6 in unstimu-
lated U1 cells did not significantly alter the RT activity Thus, we conclude that C/EBP sites are required for
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of Heidelberg, Federal Republic of Germany). In addition, some cellHIV-1 transcription in the context of virus replication. It
lines were generated using the LIP expression vector, CMV-will be important in future experiments to determine
LIP, which has been previously described (Cooper et al., 1992).whether either of the two 39 C/EBP sites alone is func-
pBABE, which contains a puromycin selectible marker, and pSV2-
tional in this replication assay and to determine how NEO, which confers resistance to G418, have been previously de-
mutation of the site(s) affects the ability of virus to repli- scribed (Morgenstern and Laud, 1990; Southern and Berg, 1982).
cate in T cell lines, peripheral blood monocytes, and
peripheral blood lymphocytes. Generation of Tetracycline U1 Cell Lines Sensitive
Previous experiments using site-directed mutagene- Cell Lines
Initially, stable U1 cell lines that expressed the tTA were generatedsis have indicated that NF-kB and Sp1 sites in the LTR
(Gossen and Bujard, 1992). Linearized pUHD15-1 (5 mg) (providedare important for HIV-1 replication, although the degree
by H. Bujard), which encodes for tTA, and 1 mg of pBABE, a plasmidof inhibition caused by mutation of the sites varies in
carrying a puromycin resistance marker, were transfected into U1
different cell lines and types (Alcami et al., 1995; Kim et cells. Transfections were performed by pulsing 300 ml of a 1.5 3
al., 1993; Leonard et al., 1989; Lu et al., 1989; Parrot et 107 cells/ml suspension at 240 V, 960 mF. Cells were resuspended
al., 1991; Ross et al., 1991). We imagine that several in 5 ml of RPMI supplemented with 10% fetal bovine serum (FBS;
Gemini Bioproducts, Calabasas, California). Cells were allowed tocellular transcription factors, including NF–IL-6, NF-kB,
recover for 24 hr before selection with 1 3 1023 mg/ml of puromycin.and Sp1 act cooperatively to activate the LTR promoter
Individual clones weregenerated by limiting dilution of the cell popu-in monocytic cells and that absence of any single com-
lation. To determine whether cell lines expressed tetracycline-de-
ponent, such as NF–IL-6, dramatically reduces promoter pendent tTA activity, transient transfection assays were performed
activity. using the tTA-responsive luciferase reporter construct, pUHC13-3.
Although we have shown that NF–IL-6 acts directly Luciferase activity was determinedas describedpreviously (Hender-
son et al., 1995). Of 16 lines tested, 3 demonstrated a 3- to 20-foldon the HIV-1 LTR, it is also clear from the work of others
decrease in their luciferase activity in the presence of 2 mg/ml ofthat NF–IL-6 activates HIV-1 transcription indirectly by
tetracycline and these lines were used for the generation of subse-inducing transcription of cytokine genes. AIDS patients
quent cell lines.
have elevated plasma levels of IL-1, IL-6, and tumor tTA-expressing lines were transfected with 5 mg of linearized
necrosis factor-a (TNFa) (Breen et al., 1990; Fauci, 1993; pUHD10-LAP or pUHD10-LIP expression constructs and 1 mg of
Harrichet al., 1989). These cytokines activate monocytic linearized pSV2–neo as described above. Clones were generated
by limiting dilution and selection in RPMI supplemented with 10%cells and induce HIV-1 replication in latently infected
FBS, 1 mg/ml G418, and 5 mg/ml of tetracycline. Some lines werecells (Koyanagi et al., 1988; Poli et al., 1990a, 1990b).
generated using 5 mg linearized CMV–LIP construct and 1 mg pSV2–IL1, IL-6, and TNFa are also produced by activated mac-
neo plasmid.
rophages, thus providing an autocrine stimulatory path-
way for HIV-1 production. Functionally important C/EBP
Western Blot Detection of NF–IL-6 and LIP Proteinssites are present in the promoters of the IL-1, IL-6, IL-8,
Whole cell extracts were prepared from different cell lines by resus-
and TNFa genes and NF–IL-6 is an important activator pending 1–2 3 106 cells in 200 ml of 23 SDS-running dye (0.2%
of these genes (Akira and Kishimoto, 1992). bromophenol blue, 4% SDS, 100 mM Tris [pH 6.8], 200 mM DTT, 3
Furthermore, the viral protein Tat has been implicated ng/ml aproptinin, 2 ng/ml pepstatin A, 1 ng/ml leupeptin, 10 mM
PMSF, 30% glycerol). Of each sample, 20 ml was loaded onto ain perpetuating an autocrine pathway in infected cells.
10% SDS–PAGE gel and the protein was transferred to 0.2 mmOne mechanism in which Tat may lead to cellular activa-
nitrocellulose filter (Schleicher and Schuell, Keene, New Hampshire)tion and further virus replication is by activating cytokine
by electroblot. The filter was blocked for 2 hr in phosphate-buffered
gene expression, transcription factors, or both. Scala et saline (PBS) with 5% nonfat milk (NFM), 0.2% Tween-20. NF–IL-6
al. (1994) have demonstrated that Tat overexpression and LIP were detected by diluting rabbit anti-NF–IL-6 antiserum
can activate endogenous IL-6. The ability of Tat to in- 1:4,000 in PBS, 2% NFM, 0.2% Tween-20 and incubating at 228C
for 2 hr. The antiserum used to detect NF–IL-6 and LIP has beencrease IL-6 expression may be, in part, due to increases
previously described (Cooper et al., 1994). Following incubation within cellular transcription factors such as NF–IL-6 and NF-
the primary antibody, the filters were washed with PBS, 0.2%kB (Scala et al., 1994), which in some latent cells could
Tween-20 three times before adding the second antibody, peroxi-
provide positive feedback by increasing cytokine and dase-conjugated goat anti-rabbit antiserum diluted 1:20,000 in PBS,
virus transcription. Taken together, the above would 2% NFM, 0.2% Tween-20. After 2 hr, the filter was washed several
suggest an interdependent relationship between host times with PBS, 0.2% Tween-20 and one time with PBS. Proteins
were then detected using the enhanced chemiluminescence Detec-transcription factors, cytokines, Tat, and HIV expression
tion System (Amersham Lifescience). For some experiments, nu-in monocytes/macrophages. Our data establish C/EBP
clear extracts prepared as previously described were used (Screiberactivators as an important component of this system,
et al., 1989).
acting directly as well as indirectly on the HIV-1 LTR.
Immunofluorescent Staining
Cells (1 3 106) were resuspended in staining media (3% newbornExperimental Procedures
calf serum, 0.02% Na azide in PBS) and the appropriate primary
antibody and incubated at 48C for 15 min. The primary antibodiesPlasmids
The tTA expression vector, pUHD15-1, and the luciferase reporter were mouse anti-human CD11b (Mac-1) and mouse anti-human-
CD54 (ICAM-1) (Dustin et al., 1986; Hoffman et al., 1980; Lubbert etconstruct, pUHC13-3, have been previously described (Gossen and
Bujard, 1992). The EcoRI–NheI fragment from pSCT–LAP (Des- al., 1991; Van Voorhis et al., 1983). All were prepared from hybridoma
supernatants and provided by Dr. M. Yellin (Columbia University).combes and Schibler, 1991) was subcloned into the EcoRI–XbaI
sites of the pUHD-10, a plasmid that contains a minimal CMV pro- Cells were then washed three times with staining medium and incu-
bated with a FITC-conjugated goat anti-mouse immunoglobulin sec-moter under the influence of tetR sequences (Gossen and Bujard,
1992). For the LIP expression construct, the EcoRI–XbaI fragment ond antibody (Jackson ImmunoResearch Laboratories) at 48C for
15 min. Cells were washed three times in staining medium andfrom pSK–LIP was subcloned into the pUHD-10. The pUHD15-1,
pUHC13-3, and PUHD10 were all provided by H. Bujard (University analyzed on a Becton Dickinson FACScan.
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RT Assays mg/ml proteinase K at 558C for 5 hr. An initial PCR of 948C for 1
min, 538C for 2 min, 728C for 2 min repeated 25 cycles using primerWe plated 100 ml of a 1 3 106 cell/ml suspension into 96-well plates
in RPMI supplemented with 10% FBS and the indicated treatments. 1 (59-GCCTGCATGGGATGGA-39), primer 3 (59-CCACTGCTAGAGAT
TTTCCAC), and 500 ng of genomic DNA was performed (Figure 7A).Cells were cultured for approximately 48 hr and supernatants were
assayed for RT activity. We added 10ml of the supernatant to 60 Of the above PCR, 1/25 was used in a second PCR using primer 2
(59 TGCATCCGGAGTACT 39), primer 3, and the same amplificationmM Tris, 24 mM DTT, 7 mM MgCl2, 75 mM NaCl, 6 mg/ml poly(dG),
12 mg/ml polyrC, 0.06% NP-40, 10 mCi [32P]adGTP in a final volume conditions (Figure 7A). Specific HIV-1 LTR sequences were detected
by Southern blots using the mC3 oligonucleotide (59 GCTGACATCGof 50 ml and incubated at 378C for 1 hr. We then transferred 5 ml of
this reaction mixture to DEAE paper and washed it twice in 23 SSC ACAGCTGTACAAGGGAC 39) as a probe. To detect all amplified LTR
sequences, the mC3 probe was allowed to hybridize for 4 hr at 258C(0.3M NaCl, 0.03M Na citrate) for 15 min at 228C (Goff et al., 1981).
RTactivity was quantifiedusing eithera bscope or a phoshorimager. in 1.5 3 SSPE, 10% polyethylene glycol, and 7% SDS. Initially filters
were washed three times at 258C in 0.2% SSC, 0.1% SDS. To detect
mC3-specific sequences, washes were performed in 0.2% SSC,Northern Blots and RNA Protection Assays
0.1% SDS at 508C.Total RNA was prepared by lysing cells with 4 M guanidium thiocya-
nate, 25 mM Na citrate, 0.5% n-lauryl sarcosine, 100 mM mercapto-
ethanol. Lysates were pelleted through a 5.7 M CsCl cushion by Acknowledgments
centrifuging for 12 hr at 36,000 rpm in a SW50 rotor (Chirgwin et
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